EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge.
Saved in:
| Title: | EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge. |
|---|---|
| Authors: | Bassil CF; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Dillon K; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Anderson GR; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Mayro B; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Askin KN; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Winter PS; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Harry S; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, MA, USA., Gruber S; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Hall TM; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Hoj JP; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Cerda-Smith C; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Hutchinson HM; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Killarney ST; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Heffernan A; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Teddy C; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Singleton KR; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Qin L; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Jubien-Girard K; Institut de Chimie de Nice UMR-CNRS 7272, Université Nice Sophia Antipolis, Nice, France., Favreau C; Mediterranean Center for Molecular Medicine (C3M), Université Côte d'Azur, Nice, France., Robert G; Mediterranean Center for Molecular Medicine (C3M), Université Côte d'Azur, Nice, France., Tivon B; Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, Israel., Livnah E; Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, Israel., London N; Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, Israel., Benhida R; Institut de Chimie de Nice UMR-CNRS 7272, Université Nice Sophia Antipolis, Nice, France.; Chemical & Biochemical Sciences Green-Process Engineering (CBS), Mohammed VI Polytechnic University, Benguerir, Morocco., Auberger P; Mediterranean Center for Molecular Medicine (C3M), Université Côte d'Azur, Nice, France., Pendergast AM; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Bar-Peled L; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, MA, USA., Lonard DM; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Martin AR; Institut de Chimie de Nice UMR-CNRS 7272, Université Nice Sophia Antipolis, Nice, France.; IBMM, University of Montpellier, CNRS ENSCM, Montpellier, France., Puissant A; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Wood KC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. kris.wood@duke.edu. |
| Source: | Nature communications [Nat Commun] 2026 Jan 14; Vol. 17 (1), pp. 1726. Date of Electronic Publication: 2026 Jan 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41535280 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bassil+CF%22">Bassil CF</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Dillon+K%22">Dillon K</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+GR%22">Anderson GR</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Mayro+B%22">Mayro B</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Askin+KN%22">Askin KN</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Winter+PS%22">Winter PS</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Harry+S%22">Harry S</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gruber+S%22">Gruber S</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Hall+TM%22">Hall TM</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Hoj+JP%22">Hoj JP</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Cerda-Smith+C%22">Cerda-Smith C</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Hutchinson+HM%22">Hutchinson HM</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Killarney+ST%22">Killarney ST</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Heffernan+A%22">Heffernan A</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Teddy+C%22">Teddy C</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Singleton+KR%22">Singleton KR</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Qin+L%22">Qin L</searchLink>; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Jubien-Girard+K%22">Jubien-Girard K</searchLink>; Institut de Chimie de Nice UMR-CNRS 7272, Université Nice Sophia Antipolis, Nice, France.<br /><searchLink fieldCode="AU" term="%22Favreau+C%22">Favreau C</searchLink>; Mediterranean Center for Molecular Medicine (C3M), Université Côte d'Azur, Nice, France.<br /><searchLink fieldCode="AU" term="%22Robert+G%22">Robert G</searchLink>; Mediterranean Center for Molecular Medicine (C3M), Université Côte d'Azur, Nice, France.<br /><searchLink fieldCode="AU" term="%22Tivon+B%22">Tivon B</searchLink>; Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Livnah+E%22">Livnah E</searchLink>; Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22London+N%22">London N</searchLink>; Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Benhida+R%22">Benhida R</searchLink>; Institut de Chimie de Nice UMR-CNRS 7272, Université Nice Sophia Antipolis, Nice, France.; Chemical & Biochemical Sciences Green-Process Engineering (CBS), Mohammed VI Polytechnic University, Benguerir, Morocco.<br /><searchLink fieldCode="AU" term="%22Auberger+P%22">Auberger P</searchLink>; Mediterranean Center for Molecular Medicine (C3M), Université Côte d'Azur, Nice, France.<br /><searchLink fieldCode="AU" term="%22Pendergast+AM%22">Pendergast AM</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Bar-Peled+L%22">Bar-Peled L</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lonard+DM%22">Lonard DM</searchLink>; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Martin+AR%22">Martin AR</searchLink>; Institut de Chimie de Nice UMR-CNRS 7272, Université Nice Sophia Antipolis, Nice, France.; IBMM, University of Montpellier, CNRS ENSCM, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Puissant+A%22">Puissant A</searchLink>; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Wood+KC%22">Wood KC</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. kris.wood@duke.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2026 Jan 14; Vol. 17 (1), pp. 1726. <i>Date of Electronic Publication: </i>2026 Jan 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41535280 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-026-68424-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1726 Titles: – TitleFull: EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bassil CF – PersonEntity: Name: NameFull: Dillon K – PersonEntity: Name: NameFull: Anderson GR – PersonEntity: Name: NameFull: Mayro B – PersonEntity: Name: NameFull: Askin KN – PersonEntity: Name: NameFull: Winter PS – PersonEntity: Name: NameFull: Harry S – PersonEntity: Name: NameFull: Gruber S – PersonEntity: Name: NameFull: Hall TM – PersonEntity: Name: NameFull: Hoj JP – PersonEntity: Name: NameFull: Cerda-Smith C – PersonEntity: Name: NameFull: Hutchinson HM – PersonEntity: Name: NameFull: Killarney ST – PersonEntity: Name: NameFull: Heffernan A – PersonEntity: Name: NameFull: Teddy C – PersonEntity: Name: NameFull: Singleton KR – PersonEntity: Name: NameFull: Qin L – PersonEntity: Name: NameFull: Jubien-Girard K – PersonEntity: Name: NameFull: Favreau C – PersonEntity: Name: NameFull: Robert G – PersonEntity: Name: NameFull: Tivon B – PersonEntity: Name: NameFull: Livnah E – PersonEntity: Name: NameFull: London N – PersonEntity: Name: NameFull: Benhida R – PersonEntity: Name: NameFull: Auberger P – PersonEntity: Name: NameFull: Pendergast AM – PersonEntity: Name: NameFull: Bar-Peled L – PersonEntity: Name: NameFull: Lonard DM – PersonEntity: Name: NameFull: Martin AR – PersonEntity: Name: NameFull: Puissant A – PersonEntity: Name: NameFull: Wood KC IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 01 Text: 2026 Jan 14 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |